GLYCOPYRROLATE\INDACATEROL: 1,711 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,711
Total FAERS Reports
452 (26.4%)
Deaths Reported
625
Hospitalizations
1,711
As Primary/Secondary Suspect
70
Life-Threatening
20
Disabilities
Active Ingredient: GLYCOPYRROLATE\INDACATEROL MALEATE ·
First Report: 1995 · Latest Report: 20230316
What Are the Most Common GLYCOPYRROLATE\INDACATEROL Side Effects?
#1 Most Reported
Dyspnoea
396 reports (23.1%)
#2 Most Reported
Cough
209 reports (12.2%)
#3 Most Reported
Death
200 reports (11.7%)
All GLYCOPYRROLATE\INDACATEROL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 396 | 23.1% | 54 | 232 |
| Cough | 209 | 12.2% | 14 | 74 |
| Death | 200 | 11.7% | 198 | 30 |
| Product use in unapproved indication | 170 | 9.9% | 37 | 72 |
| Malaise | 166 | 9.7% | 23 | 81 |
| Chronic obstructive pulmonary disease | 156 | 9.1% | 30 | 93 |
| Wheezing | 137 | 8.0% | 3 | 92 |
| Asthma | 125 | 7.3% | 5 | 92 |
| Fatigue | 122 | 7.1% | 8 | 44 |
| Drug ineffective | 106 | 6.2% | 10 | 44 |
| Pneumonia | 106 | 6.2% | 39 | 78 |
| Lung disorder | 80 | 4.7% | 19 | 46 |
| Weight decreased | 71 | 4.2% | 14 | 31 |
| Emphysema | 69 | 4.0% | 27 | 32 |
| Lung neoplasm malignant | 64 | 3.7% | 28 | 14 |
| Loss of personal independence in daily activities | 63 | 3.7% | 0 | 57 |
| Productive cough | 58 | 3.4% | 4 | 30 |
| Weight increased | 58 | 3.4% | 2 | 30 |
| Asthenia | 56 | 3.3% | 10 | 25 |
| Cardiac disorder | 54 | 3.2% | 17 | 33 |
Who Reports GLYCOPYRROLATE\INDACATEROL Side Effects? Age & Gender Data
Gender: 46.7% female, 53.3% male. Average age: 69.9 years. Most reports from: BR. View detailed demographics →
Is GLYCOPYRROLATE\INDACATEROL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 1 | 0 |
| 2006 | 2 | 0 | 0 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 1 | 1 |
| 2014 | 7 | 1 | 3 |
| 2015 | 30 | 4 | 17 |
| 2016 | 77 | 18 | 30 |
| 2017 | 255 | 77 | 116 |
| 2018 | 151 | 56 | 59 |
| 2019 | 85 | 38 | 28 |
| 2020 | 10 | 4 | 5 |
| 2021 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
What Is GLYCOPYRROLATE\INDACATEROL Used For?
| Indication | Reports |
|---|---|
| Chronic obstructive pulmonary disease | 745 |
| Product used for unknown indication | 559 |
| Emphysema | 182 |
| Asthma | 96 |
| Dyspnoea | 55 |
| Lung disorder | 35 |
| Bronchitis | 20 |
| Bronchitis chronic | 15 |
| Pneumonia | 14 |
| Pulmonary fibrosis | 13 |
GLYCOPYRROLATE\INDACATEROL vs Alternatives: Which Is Safer?
GLYCOPYRROLATE\INDACATEROL vs GLYCOPYRROLATE\INDACATEROL\MOMETASONE FUROATE
GLYCOPYRROLATE\INDACATEROL vs GLYCOPYRRONIUM
GLYCOPYRROLATE\INDACATEROL vs GLYCOPYRRONIUM\INDACATEROL
GLYCOPYRROLATE\INDACATEROL vs GOLD
GLYCOPYRROLATE\INDACATEROL vs GOLD THIOMALATE
GLYCOPYRROLATE\INDACATEROL vs GOLIMUMAB
GLYCOPYRROLATE\INDACATEROL vs GOLODIRSEN
GLYCOPYRROLATE\INDACATEROL vs GONADORELIN
GLYCOPYRROLATE\INDACATEROL vs GONADOTROPHIN, CHORIONIC
GLYCOPYRROLATE\INDACATEROL vs GOSERELIN
Official FDA Label for GLYCOPYRROLATE\INDACATEROL
Official prescribing information from the FDA-approved drug label.